PTJ
TBIO

Paul Tudor Jones’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Paul Tudor Jones’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,214
Closed -$430K – 2816
2021
Q4 		$430K Sell
2,214
-283
-11% -$44K 0.01% 1581
2021
Q3 		$500K Sell
2,497
-281
-10% -$71.3K 0.01% 1652
2021
Q2 		$1.1M Buy
+2,778
New +$982K 0.02% 825

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paul Tudor Jones's TBIO Position: Q1 2022 in Review

Paul Tudor Jones sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q1 2022, closing a stake of 2,214 shares — an estimated $430K sold.

Paul Tudor Jones first reported a position in TBIO in Q2 2021 and held it in 3 quarters. The position peaked at $1.1M in Q2 2021. 47 funds tracked by Wall St. Rank hold TBIO as of Q1 2022.

  • Paul Tudor Jones reported no remaining Telesis Bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Paul Tudor Jones sold 2,214 Telesis Bio, Inc. Common Stock shares in Q1 2022, an estimated $430K.
  • Paul Tudor Jones first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Paul Tudor Jones's Telesis Bio, Inc. Common Stock position peaked at $1.1M in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.